Zambon, a multinational chemical-pharmaceutical company founded on the history and values of an Italian family and committed to innovate cure and care to make patients’ lives better, announces the ...

Zambon Pharma has received approval from Chinese regulatory authorities and launched Fluimucil (N-acetylcysteine).

Fluimucil IV is now available to patients across China as an essential hospital-based treatment for respiratory conditions. Credit: Explode/Shutterstock.

The intravenous formulation of Fluimucil® will initially be distributed in a selection of Chinese hospitals and represents another step forward in Zambon's expansion strategy in the Chinese market.

" The approval of Fluimucil® IV in China is a major recognition of the scientific rigor with which we conducted the clinical trials and the quality of our collaboration with local research ...

MILAN, June 24, 2025--Zambon, a multinational chemical-pharmaceutical company founded on the history and values of an Italian family and committed to innovate cure and care to make patients’ lives ...

Understanding the body’s response to these ailments and how products like Fluimucil can offer relief, is key to navigating these common, yet disruptive, health issues. Read more Read more at ...

Learn everything you need to know about Acetylcysteine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions ...

He said that in the three months from August to October 2023, his clinic saw 326 cases of cough and 345 cases of runny nose. From November 2023 to January so far, the figures have gone up to 553 ...